Trials / NCT02575430
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT
Completed Observational Natural history / observational
- Sponsor
- QLT Inc.
- Treatment
- No treatment: retrospective chart review
- Gene
- RPE65
- Conditions
- Leber Congenital Amaurosis (LCA), Retinitis Pigmentosa (RP)
- Ages
- 8 Years to no upper limit
- Enrollment
- 59 participants
- Started
- 2015-12
- Main results expected
- 2016-03
- Results posted
- Not yet
- Record last updated
- 2016-04-29
What the study is testing
To evaluate the natural history of visual function in subjects with IRD phenotypically diagnosed as Leber congenital amaurosis (LCA) or retinitis pigmentosa (RP) caused by RPE65 or LRAT gene mutations.
Where it runs
Canada (2)
- The Hospital for Sick Children, Ophthalmology and Vision Sciences, Toronto, Ontario
- Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec
Denmark (1)
- Glostrup Hospital and National Eye Clinic at the Kennedy Center, Glostrup Municipality, Copenhagen
Germany (1)
- STZ Eyetrial at the Department of Ophthalmology - University of Tübingen, Tübingen
Netherlands (1)
- Rotterdam Ophthalmic Institute, Rotterdam
Switzerland (1)
- Jules Gonin Eye Hospital - Oculogenetic Unit, Lausanne
United Kingdom (1)
- Moorfields Eye Hospital - Research and Treatment Centre, London
United States (2)
- Wilmer Eye Institute - Johns Hopkins Hospital, Baltimore, Maryland
- Casey Eye Institute - Marquam Hill, Portland, Oregon